The global Tumor NGS Genetic Testing market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Liquid Biopsy (Blood Sample) Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Tumor NGS Genetic Testing include Foundation Medicine, Guardant Health, Illumina, Thermo Fisher Scientific Inc., DIAN DIAGNOSTICS Group Co., Ltd., Burning Rock Biotech., NovogeneCo.,Ltd., Nanjing Shihejiyin Technology, Inc. and Amoy Diagnostics Co.,Ltd., etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Tumor NGS Genetic Testing is to use high-throughput sequencing to understand tumors at the genetic level, detect and quantify the genetic components that drive tumors.
This report aims to provide a comprehensive presentation of the global market for Tumor NGS Genetic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor NGS Genetic Testing. This report contains market size and forecasts of Tumor NGS Genetic Testing in global, including the following market information:
Global Tumor NGS Genetic Testing Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Tumor NGS Genetic Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tumor NGS Genetic Testing Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Tumor NGS Genetic Testing Market Segment Percentages, by Type, 2023 (%)
Liquid Biopsy (Blood Sample)
Tissue Biopsy
Global Tumor NGS Genetic Testing Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Tumor NGS Genetic Testing Market Segment Percentages, by Application, 2023 (%)
Companion Diagnostics
Early Cancer Screening
Drug Discovery
Global Tumor NGS Genetic Testing Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Tumor NGS Genetic Testing Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tumor NGS Genetic Testing revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Tumor NGS Genetic Testing revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Foundation Medicine
Guardant Health
Illumina
Thermo Fisher Scientific Inc.
DIAN DIAGNOSTICS Group Co., Ltd.
Burning Rock Biotech.
NovogeneCo.,Ltd.
Nanjing Shihejiyin Technology, Inc.
Amoy Diagnostics Co.,Ltd.
China National Pharmaceutical Group Corporation
Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.
Guangzhou Kingmed Diagnostics Group Co.,Ltd.
ADICON Clinical Laboratories, Inc.
Genetron
Genecast Group Inc.
BGI Genomics Co.,Ltd.
Beijing-Geneplus Technology Limited.
Xiamen SpacegenCo., Ltd.
Geneis?Beijing?Co.Ltd.
HaploX
Outline of Major Chapters:
Chapter 1: Introduces the definition of Tumor NGS Genetic Testing, market overview.
Chapter 2: Global Tumor NGS Genetic Testing market size in revenue.
Chapter 3: Detailed analysis of Tumor NGS Genetic Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Tumor NGS Genetic Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Tumor NGS Genetic Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Tumor NGS Genetic Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Tumor NGS Genetic Testing Overall Market Size
2.1 Global Tumor NGS Genetic Testing Market Size: 2023 VS 2030
2.2 Global Tumor NGS Genetic Testing Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Tumor NGS Genetic Testing Players in Global Market
3.2 Top Global Tumor NGS Genetic Testing Companies Ranked by Revenue
3.3 Global Tumor NGS Genetic Testing Revenue by Companies
3.4 Top 3 and Top 5 Tumor NGS Genetic Testing Companies in Global Market, by Revenue in 2023
3.5 Global Companies Tumor NGS Genetic Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Tumor NGS Genetic Testing Players in Global Market
3.6.1 List of Global Tier 1 Tumor NGS Genetic Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Tumor NGS Genetic Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Tumor NGS Genetic Testing Market Size Markets, 2023 & 2030
4.1.2 Liquid Biopsy (Blood Sample)
4.1.3 Tissue Biopsy
4.2 By Type - Global Tumor NGS Genetic Testing Revenue & Forecasts
4.2.1 By Type - Global Tumor NGS Genetic Testing Revenue, 2019-2024
4.2.2 By Type - Global Tumor NGS Genetic Testing Revenue, 2025-2030
4.2.3 By Type - Global Tumor NGS Genetic Testing Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Tumor NGS Genetic Testing Market Size, 2023 & 2030
5.1.2 Companion Diagnostics
5.1.3 Early Cancer Screening
5.1.4 Drug Discovery
5.2 By Application - Global Tumor NGS Genetic Testing Revenue & Forecasts
5.2.1 By Application - Global Tumor NGS Genetic Testing Revenue, 2019-2024
5.2.2 By Application - Global Tumor NGS Genetic Testing Revenue, 2025-2030
5.2.3 By Application - Global Tumor NGS Genetic Testing Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Tumor NGS Genetic Testing Market Size, 2023 & 2030
6.2 By Region - Global Tumor NGS Genetic Testing Revenue & Forecasts
6.2.1 By Region - Global Tumor NGS Genetic Testing Revenue, 2019-2024
6.2.2 By Region - Global Tumor NGS Genetic Testing Revenue, 2025-2030
6.2.3 By Region - Global Tumor NGS Genetic Testing Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Tumor NGS Genetic Testing Revenue, 2019-2030
6.3.2 US Tumor NGS Genetic Testing Market Size, 2019-2030
6.3.3 Canada Tumor NGS Genetic Testing Market Size, 2019-2030
6.3.4 Mexico Tumor NGS Genetic Testing Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Tumor NGS Genetic Testing Revenue, 2019-2030
6.4.2 Germany Tumor NGS Genetic Testing Market Size, 2019-2030
6.4.3 France Tumor NGS Genetic Testing Market Size, 2019-2030
6.4.4 U.K. Tumor NGS Genetic Testing Market Size, 2019-2030
6.4.5 Italy Tumor NGS Genetic Testing Market Size, 2019-2030
6.4.6 Russia Tumor NGS Genetic Testing Market Size, 2019-2030
6.4.7 Nordic Countries Tumor NGS Genetic Testing Market Size, 2019-2030
6.4.8 Benelux Tumor NGS Genetic Testing Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Tumor NGS Genetic Testing Revenue, 2019-2030
6.5.2 China Tumor NGS Genetic Testing Market Size, 2019-2030
6.5.3 Japan Tumor NGS Genetic Testing Market Size, 2019-2030
6.5.4 South Korea Tumor NGS Genetic Testing Market Size, 2019-2030
6.5.5 Southeast Asia Tumor NGS Genetic Testing Market Size, 2019-2030
6.5.6 India Tumor NGS Genetic Testing Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Tumor NGS Genetic Testing Revenue, 2019-2030
6.6.2 Brazil Tumor NGS Genetic Testing Market Size, 2019-2030
6.6.3 Argentina Tumor NGS Genetic Testing Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Tumor NGS Genetic Testing Revenue, 2019-2030
6.7.2 Turkey Tumor NGS Genetic Testing Market Size, 2019-2030
6.7.3 Israel Tumor NGS Genetic Testing Market Size, 2019-2030
6.7.4 Saudi Arabia Tumor NGS Genetic Testing Market Size, 2019-2030
6.7.5 UAE Tumor NGS Genetic Testing Market Size, 2019-2030
7 Tumor NGS Genetic Testing Companies Profiles
7.1 Foundation Medicine
7.1.1 Foundation Medicine Company Summary
7.1.2 Foundation Medicine Business Overview
7.1.3 Foundation Medicine Tumor NGS Genetic Testing Major Product Offerings
7.1.4 Foundation Medicine Tumor NGS Genetic Testing Revenue in Global Market (2019-2024)
7.1.5 Foundation Medicine Key News & Latest Developments
7.2 Guardant Health
7.2.1 Guardant Health Company Summary
7.2.2 Guardant Health Business Overview
7.2.3 Guardant Health Tumor NGS Genetic Testing Major Product Offerings
7.2.4 Guardant Health Tumor NGS Genetic Testing Revenue in Global Market (2019-2024)
7.2.5 Guardant Health Key News & Latest Developments
7.3 Illumina
7.3.1 Illumina Company Summary
7.3.2 Illumina Business Overview
7.3.3 Illumina Tumor NGS Genetic Testing Major Product Offerings
7.3.4 Illumina Tumor NGS Genetic Testing Revenue in Global Market (2019-2024)
7.3.5 Illumina Key News & Latest Developments
7.4 Thermo Fisher Scientific Inc.
7.4.1 Thermo Fisher Scientific Inc. Company Summary
7.4.2 Thermo Fisher Scientific Inc. Business Overview
7.4.3 Thermo Fisher Scientific Inc. Tumor NGS Genetic Testing Major Product Offerings
7.4.4 Thermo Fisher Scientific Inc. Tumor NGS Genetic Testing Revenue in Global Market (2019-2024)
7.4.5 Thermo Fisher Scientific Inc. Key News & Latest Developments
7.5 DIAN DIAGNOSTICS Group Co., Ltd.
7.5.1 DIAN DIAGNOSTICS Group Co., Ltd. Company Summary
7.5.2 DIAN DIAGNOSTICS Group Co., Ltd. Business Overview
7.5.3 DIAN DIAGNOSTICS Group Co., Ltd. Tumor NGS Genetic Testing Major Product Offerings
7.5.4 DIAN DIAGNOSTICS Group Co., Ltd. Tumor NGS Genetic Testing Revenue in Global Market (2019-2024)
7.5.5 DIAN DIAGNOSTICS Group Co., Ltd. Key News & Latest Developments
7.6 Burning Rock Biotech.
7.6.1 Burning Rock Biotech. Company Summary
7.6.2 Burning Rock Biotech. Business Overview
7.6.3 Burning Rock Biotech. Tumor NGS Genetic Testing Major Product Offerings
7.6.4 Burning Rock Biotech. Tumor NGS Genetic Testing Revenue in Global Market (2019-2024)
7.6.5 Burning Rock Biotech. Key News & Latest Developments
7.7 NovogeneCo.,Ltd.
7.7.1 NovogeneCo.,Ltd. Company Summary
7.7.2 NovogeneCo.,Ltd. Business Overview
7.7.3 NovogeneCo.,Ltd. Tumor NGS Genetic Testing Major Product Offerings
7.7.4 NovogeneCo.,Ltd. Tumor NGS Genetic Testing Revenue in Global Market (2019-2024)
7.7.5 NovogeneCo.,Ltd. Key News & Latest Developments
7.8 Nanjing Shihejiyin Technology, Inc.
7.8.1 Nanjing Shihejiyin Technology, Inc. Company Summary
7.8.2 Nanjing Shihejiyin Technology, Inc. Business Overview
7.8.3 Nanjing Shihejiyin Technology, Inc. Tumor NGS Genetic Testing Major Product Offerings
7.8.4 Nanjing Shihejiyin Technology, Inc. Tumor NGS Genetic Testing Revenue in Global Market (2019-2024)
7.8.5 Nanjing Shihejiyin Technology, Inc. Key News & Latest Developments
7.9 Amoy Diagnostics Co.,Ltd.
7.9.1 Amoy Diagnostics Co.,Ltd. Company Summary
7.9.2 Amoy Diagnostics Co.,Ltd. Business Overview
7.9.3 Amoy Diagnostics Co.,Ltd. Tumor NGS Genetic Testing Major Product Offerings
7.9.4 Amoy Diagnostics Co.,Ltd. Tumor NGS Genetic Testing Revenue in Global Market (2019-2024)
7.9.5 Amoy Diagnostics Co.,Ltd. Key News & Latest Developments
7.10 China National Pharmaceutical Group Corporation
7.10.1 China National Pharmaceutical Group Corporation Company Summary
7.10.2 China National Pharmaceutical Group Corporation Business Overview
7.10.3 China National Pharmaceutical Group Corporation Tumor NGS Genetic Testing Major Product Offerings
7.10.4 China National Pharmaceutical Group Corporation Tumor NGS Genetic Testing Revenue in Global Market (2019-2024)
7.10.5 China National Pharmaceutical Group Corporation Key News & Latest Developments
7.11 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.
7.11.1 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Company Summary
7.11.2 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Business Overview
7.11.3 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Tumor NGS Genetic Testing Major Product Offerings
7.11.4 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Tumor NGS Genetic Testing Revenue in Global Market (2019-2024)
7.11.5 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Key News & Latest Developments
7.12 Guangzhou Kingmed Diagnostics Group Co.,Ltd.
7.12.1 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Company Summary
7.12.2 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Business Overview
7.12.3 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Tumor NGS Genetic Testing Major Product Offerings
7.12.4 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Tumor NGS Genetic Testing Revenue in Global Market (2019-2024)
7.12.5 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Key News & Latest Developments
7.13 ADICON Clinical Laboratories, Inc.
7.13.1 ADICON Clinical Laboratories, Inc. Company Summary
7.13.2 ADICON Clinical Laboratories, Inc. Business Overview
7.13.3 ADICON Clinical Laboratories, Inc. Tumor NGS Genetic Testing Major Product Offerings
7.13.4 ADICON Clinical Laboratories, Inc. Tumor NGS Genetic Testing Revenue in Global Market (2019-2024)
7.13.5 ADICON Clinical Laboratories, Inc. Key News & Latest Developments
7.14 Genetron
7.14.1 Genetron Company Summary
7.14.2 Genetron Business Overview
7.14.3 Genetron Tumor NGS Genetic Testing Major Product Offerings
7.14.4 Genetron Tumor NGS Genetic Testing Revenue in Global Market (2019-2024)
7.14.5 Genetron Key News & Latest Developments
7.15 Genecast Group Inc.
7.15.1 Genecast Group Inc. Company Summary
7.15.2 Genecast Group Inc. Business Overview
7.15.3 Genecast Group Inc. Tumor NGS Genetic Testing Major Product Offerings
7.15.4 Genecast Group Inc. Tumor NGS Genetic Testing Revenue in Global Market (2019-2024)
7.15.5 Genecast Group Inc. Key News & Latest Developments
7.16 BGI Genomics Co.,Ltd.
7.16.1 BGI Genomics Co.,Ltd. Company Summary
7.16.2 BGI Genomics Co.,Ltd. Business Overview
7.16.3 BGI Genomics Co.,Ltd. Tumor NGS Genetic Testing Major Product Offerings
7.16.4 BGI Genomics Co.,Ltd. Tumor NGS Genetic Testing Revenue in Global Market (2019-2024)
7.16.5 BGI Genomics Co.,Ltd. Key News & Latest Developments
7.17 Beijing-Geneplus Technology Limited.
7.17.1 Beijing-Geneplus Technology Limited. Company Summary
7.17.2 Beijing-Geneplus Technology Limited. Business Overview
7.17.3 Beijing-Geneplus Technology Limited. Tumor NGS Genetic Testing Major Product Offerings
7.17.4 Beijing-Geneplus Technology Limited. Tumor NGS Genetic Testing Revenue in Global Market (2019-2024)
7.17.5 Beijing-Geneplus Technology Limited. Key News & Latest Developments
7.18 Xiamen SpacegenCo., Ltd.
7.18.1 Xiamen SpacegenCo., Ltd. Company Summary
7.18.2 Xiamen SpacegenCo., Ltd. Business Overview
7.18.3 Xiamen SpacegenCo., Ltd. Tumor NGS Genetic Testing Major Product Offerings
7.18.4 Xiamen SpacegenCo., Ltd. Tumor NGS Genetic Testing Revenue in Global Market (2019-2024)
7.18.5 Xiamen SpacegenCo., Ltd. Key News & Latest Developments
7.19 Geneis?Beijing?Co.Ltd.
7.19.1 Geneis?Beijing?Co.Ltd. Company Summary
7.19.2 Geneis?Beijing?Co.Ltd. Business Overview
7.19.3 Geneis?Beijing?Co.Ltd. Tumor NGS Genetic Testing Major Product Offerings
7.19.4 Geneis?Beijing?Co.Ltd. Tumor NGS Genetic Testing Revenue in Global Market (2019-2024)
7.19.5 Geneis?Beijing?Co.Ltd. Key News & Latest Developments
7.20 HaploX
7.20.1 HaploX Company Summary
7.20.2 HaploX Business Overview
7.20.3 HaploX Tumor NGS Genetic Testing Major Product Offerings
7.20.4 HaploX Tumor NGS Genetic Testing Revenue in Global Market (2019-2024)
7.20.5 HaploX Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Tumor NGS Genetic Testing Market Opportunities & Trends in Global Market
Table 2. Tumor NGS Genetic Testing Market Drivers in Global Market
Table 3. Tumor NGS Genetic Testing Market Restraints in Global Market
Table 4. Key Players of Tumor NGS Genetic Testing in Global Market
Table 5. Top Tumor NGS Genetic Testing Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Tumor NGS Genetic Testing Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Tumor NGS Genetic Testing Revenue Share by Companies, 2019-2024
Table 8. Global Companies Tumor NGS Genetic Testing Product Type
Table 9. List of Global Tier 1 Tumor NGS Genetic Testing Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Tumor NGS Genetic Testing Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Tumor NGS Genetic Testing Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Tumor NGS Genetic Testing Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Tumor NGS Genetic Testing Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Tumor NGS Genetic Testing Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Tumor NGS Genetic Testing Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Tumor NGS Genetic Testing Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Tumor NGS Genetic Testing Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Tumor NGS Genetic Testing Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Tumor NGS Genetic Testing Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Tumor NGS Genetic Testing Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Tumor NGS Genetic Testing Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Tumor NGS Genetic Testing Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Tumor NGS Genetic Testing Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Tumor NGS Genetic Testing Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Tumor NGS Genetic Testing Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Tumor NGS Genetic Testing Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Tumor NGS Genetic Testing Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Tumor NGS Genetic Testing Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Tumor NGS Genetic Testing Revenue, (US$, Mn), 2025-2030
Table 30. Foundation Medicine Company Summary
Table 31. Foundation Medicine Tumor NGS Genetic Testing Product Offerings
Table 32. Foundation Medicine Tumor NGS Genetic Testing Revenue (US$, Mn) & (2019-2024)
Table 33. Foundation Medicine Key News & Latest Developments
Table 34. Guardant Health Company Summary
Table 35. Guardant Health Tumor NGS Genetic Testing Product Offerings
Table 36. Guardant Health Tumor NGS Genetic Testing Revenue (US$, Mn) & (2019-2024)
Table 37. Guardant Health Key News & Latest Developments
Table 38. Illumina Company Summary
Table 39. Illumina Tumor NGS Genetic Testing Product Offerings
Table 40. Illumina Tumor NGS Genetic Testing Revenue (US$, Mn) & (2019-2024)
Table 41. Illumina Key News & Latest Developments
Table 42. Thermo Fisher Scientific Inc. Company Summary
Table 43. Thermo Fisher Scientific Inc. Tumor NGS Genetic Testing Product Offerings
Table 44. Thermo Fisher Scientific Inc. Tumor NGS Genetic Testing Revenue (US$, Mn) & (2019-2024)
Table 45. Thermo Fisher Scientific Inc. Key News & Latest Developments
Table 46. DIAN DIAGNOSTICS Group Co., Ltd. Company Summary
Table 47. DIAN DIAGNOSTICS Group Co., Ltd. Tumor NGS Genetic Testing Product Offerings
Table 48. DIAN DIAGNOSTICS Group Co., Ltd. Tumor NGS Genetic Testing Revenue (US$, Mn) & (2019-2024)
Table 49. DIAN DIAGNOSTICS Group Co., Ltd. Key News & Latest Developments
Table 50. Burning Rock Biotech. Company Summary
Table 51. Burning Rock Biotech. Tumor NGS Genetic Testing Product Offerings
Table 52. Burning Rock Biotech. Tumor NGS Genetic Testing Revenue (US$, Mn) & (2019-2024)
Table 53. Burning Rock Biotech. Key News & Latest Developments
Table 54. NovogeneCo.,Ltd. Company Summary
Table 55. NovogeneCo.,Ltd. Tumor NGS Genetic Testing Product Offerings
Table 56. NovogeneCo.,Ltd. Tumor NGS Genetic Testing Revenue (US$, Mn) & (2019-2024)
Table 57. NovogeneCo.,Ltd. Key News & Latest Developments
Table 58. Nanjing Shihejiyin Technology, Inc. Company Summary
Table 59. Nanjing Shihejiyin Technology, Inc. Tumor NGS Genetic Testing Product Offerings
Table 60. Nanjing Shihejiyin Technology, Inc. Tumor NGS Genetic Testing Revenue (US$, Mn) & (2019-2024)
Table 61. Nanjing Shihejiyin Technology, Inc. Key News & Latest Developments
Table 62. Amoy Diagnostics Co.,Ltd. Company Summary
Table 63. Amoy Diagnostics Co.,Ltd. Tumor NGS Genetic Testing Product Offerings
Table 64. Amoy Diagnostics Co.,Ltd. Tumor NGS Genetic Testing Revenue (US$, Mn) & (2019-2024)
Table 65. Amoy Diagnostics Co.,Ltd. Key News & Latest Developments
Table 66. China National Pharmaceutical Group Corporation Company Summary
Table 67. China National Pharmaceutical Group Corporation Tumor NGS Genetic Testing Product Offerings
Table 68. China National Pharmaceutical Group Corporation Tumor NGS Genetic Testing Revenue (US$, Mn) & (2019-2024)
Table 69. China National Pharmaceutical Group Corporation Key News & Latest Developments
Table 70. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Company Summary
Table 71. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Tumor NGS Genetic Testing Product Offerings
Table 72. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Tumor NGS Genetic Testing Revenue (US$, Mn) & (2019-2024)
Table 73. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Key News & Latest Developments
Table 74. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Company Summary
Table 75. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Tumor NGS Genetic Testing Product Offerings
Table 76. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Tumor NGS Genetic Testing Revenue (US$, Mn) & (2019-2024)
Table 77. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Key News & Latest Developments
Table 78. ADICON Clinical Laboratories, Inc. Company Summary
Table 79. ADICON Clinical Laboratories, Inc. Tumor NGS Genetic Testing Product Offerings
Table 80. ADICON Clinical Laboratories, Inc. Tumor NGS Genetic Testing Revenue (US$, Mn) & (2019-2024)
Table 81. ADICON Clinical Laboratories, Inc. Key News & Latest Developments
Table 82. Genetron Company Summary
Table 83. Genetron Tumor NGS Genetic Testing Product Offerings
Table 84. Genetron Tumor NGS Genetic Testing Revenue (US$, Mn) & (2019-2024)
Table 85. Genetron Key News & Latest Developments
Table 86. Genecast Group Inc. Company Summary
Table 87. Genecast Group Inc. Tumor NGS Genetic Testing Product Offerings
Table 88. Genecast Group Inc. Tumor NGS Genetic Testing Revenue (US$, Mn) & (2019-2024)
Table 89. Genecast Group Inc. Key News & Latest Developments
Table 90. BGI Genomics Co.,Ltd. Company Summary
Table 91. BGI Genomics Co.,Ltd. Tumor NGS Genetic Testing Product Offerings
Table 92. BGI Genomics Co.,Ltd. Tumor NGS Genetic Testing Revenue (US$, Mn) & (2019-2024)
Table 93. BGI Genomics Co.,Ltd. Key News & Latest Developments
Table 94. Beijing-Geneplus Technology Limited. Company Summary
Table 95. Beijing-Geneplus Technology Limited. Tumor NGS Genetic Testing Product Offerings
Table 96. Beijing-Geneplus Technology Limited. Tumor NGS Genetic Testing Revenue (US$, Mn) & (2019-2024)
Table 97. Beijing-Geneplus Technology Limited. Key News & Latest Developments
Table 98. Xiamen SpacegenCo., Ltd. Company Summary
Table 99. Xiamen SpacegenCo., Ltd. Tumor NGS Genetic Testing Product Offerings
Table 100. Xiamen SpacegenCo., Ltd. Tumor NGS Genetic Testing Revenue (US$, Mn) & (2019-2024)
Table 101. Xiamen SpacegenCo., Ltd. Key News & Latest Developments
Table 102. Geneis?Beijing?Co.Ltd. Company Summary
Table 103. Geneis?Beijing?Co.Ltd. Tumor NGS Genetic Testing Product Offerings
Table 104. Geneis?Beijing?Co.Ltd. Tumor NGS Genetic Testing Revenue (US$, Mn) & (2019-2024)
Table 105. Geneis?Beijing?Co.Ltd. Key News & Latest Developments
Table 106. HaploX Company Summary
Table 107. HaploX Tumor NGS Genetic Testing Product Offerings
Table 108. HaploX Tumor NGS Genetic Testing Revenue (US$, Mn) & (2019-2024)
Table 109. HaploX Key News & Latest Developments
List of Figures
Figure 1. Tumor NGS Genetic Testing Segment by Type in 2023
Figure 2. Tumor NGS Genetic Testing Segment by Application in 2023
Figure 3. Global Tumor NGS Genetic Testing Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Tumor NGS Genetic Testing Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Tumor NGS Genetic Testing Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Tumor NGS Genetic Testing Revenue in 2023
Figure 8. By Type - Global Tumor NGS Genetic Testing Revenue Market Share, 2019-2030
Figure 9. By Application - Global Tumor NGS Genetic Testing Revenue Market Share, 2019-2030
Figure 10. By Type - Global Tumor NGS Genetic Testing Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Tumor NGS Genetic Testing Revenue Market Share, 2019-2030
Figure 12. By Application - Global Tumor NGS Genetic Testing Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Tumor NGS Genetic Testing Revenue Market Share, 2019-2030
Figure 14. By Region - Global Tumor NGS Genetic Testing Revenue Market Share, 2019-2030
Figure 15. By Country - North America Tumor NGS Genetic Testing Revenue Market Share, 2019-2030
Figure 16. US Tumor NGS Genetic Testing Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Tumor NGS Genetic Testing Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Tumor NGS Genetic Testing Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Tumor NGS Genetic Testing Revenue Market Share, 2019-2030
Figure 20. Germany Tumor NGS Genetic Testing Revenue, (US$, Mn), 2019-2030
Figure 21. France Tumor NGS Genetic Testing Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Tumor NGS Genetic Testing Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Tumor NGS Genetic Testing Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Tumor NGS Genetic Testing Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Tumor NGS Genetic Testing Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Tumor NGS Genetic Testing Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Tumor NGS Genetic Testing Revenue Market Share, 2019-2030
Figure 28. China Tumor NGS Genetic Testing Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Tumor NGS Genetic Testing Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Tumor NGS Genetic Testing Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Tumor NGS Genetic Testing Revenue, (US$, Mn), 2019-2030
Figure 32. India Tumor NGS Genetic Testing Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Tumor NGS Genetic Testing Revenue Market Share, 2019-2030
Figure 34. Brazil Tumor NGS Genetic Testing Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Tumor NGS Genetic Testing Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Tumor NGS Genetic Testing Revenue Market Share, 2019-2030
Figure 37. Turkey Tumor NGS Genetic Testing Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Tumor NGS Genetic Testing Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Tumor NGS Genetic Testing Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Tumor NGS Genetic Testing Revenue, (US$, Mn), 2019-2030
Figure 41. Foundation Medicine Tumor NGS Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Guardant Health Tumor NGS Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Illumina Tumor NGS Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Thermo Fisher Scientific Inc. Tumor NGS Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. DIAN DIAGNOSTICS Group Co., Ltd. Tumor NGS Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Burning Rock Biotech. Tumor NGS Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. NovogeneCo.,Ltd. Tumor NGS Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Nanjing Shihejiyin Technology, Inc. Tumor NGS Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Amoy Diagnostics Co.,Ltd. Tumor NGS Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. China National Pharmaceutical Group Corporation Tumor NGS Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Tumor NGS Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Tumor NGS Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. ADICON Clinical Laboratories, Inc. Tumor NGS Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 54. Genetron Tumor NGS Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 55. Genecast Group Inc. Tumor NGS Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 56. BGI Genomics Co.,Ltd. Tumor NGS Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 57. Beijing-Geneplus Technology Limited. Tumor NGS Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 58. Xiamen SpacegenCo., Ltd. Tumor NGS Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 59. Geneis?Beijing?Co.Ltd. Tumor NGS Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 60. HaploX Tumor NGS Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
